LoginRegister

    AstraZeneca Pharma India Q2 net profit dips 67% to Rs 9.13 Crore

    Medical Dialogues BureauWritten by Medical Dialogues Bureau   |  
    AstraZeneca Pharma India Q2 net profit dips 67% to Rs 9.13 Crore

    New Delhi: Drug firm AstraZeneca Pharma India has recently reported a 66.65 per cent dip in its net profit to Rs 9.13 crore for the quarter ended September 30, 2018. The company had posted a net profit of Rs 27.38 crore for the corresponding period of the previous fiscal, AstraZeneca Pharma India said in a filing to BSE.


    Company's total revenue for the quarter under consideration stood at Rs 164.71 crore. It was Rs 166.75 crore for the same period year ago.

    AstraZeneca Pharma India Limited is the Indian subsidiary of the global biopharmaceutical company AstraZeneca Plc, UK.


    Read Also: AstraZeneca’s Diabetic drug Farxiga curbs heart failure, kidney risks
    AstraZeneca PharmaAstraZeneca PLCprevious fiscalprofit dips 67 percentRs 9.13 Crore
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

      © 2020 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X